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Abstract 
Background and Purpose: Research indicates a positive relationship between family support 
and glycemic control for individuals with type 2 diabetes mellitus (T2DM). The purpose of this 
Doctor of Nursing Practice (DNP) final project was to evaluate the effect of family support on 
the management of T2DM and associated improvement in glycemic control.   
Methods: In this prospective cohort design based on a computed power analysis, 20 participants 
were recruited: 10 in the intervention group and 10 in the control group.  A total of nine 
participants completed the study.  The intervention group received tailored education on family 
interaction based on the work of Satir (1967) to encourage their support and enhance 
communication.  The control group received standard education based on current diabetic 
education protocols for Riverside Medical Group.  Analysis of covariance (ANCOVA) was set at 
a level of significance of p ≤ 0.01 for this final DNP project.   
Evaluation: The participants’ pre and post-intervention hemoglobin-A1c levels were evaluated.  
It was hypothesized that tailored education focused on positive family support would correspond 
to increased glycemic control in patients with T2DM.  Findings indicate no statistical 
significance between the tailored education to enhance family support and glycemic control. 
Clinical Implications and Recommendations: T2DM is a highly variable disease, and no 
specific educational or social intervention or medication will independently increase glycemic 
control for all patients.  
Keywords: diabetes mellitus type 2, non-insulin dependent diabetes mellitus, diabetes mellitus, 
adult onset, diabetes mellitus, noninsulin-dependent, diabetes mellitus, type II, glycemic control, 
glycemic index, primary care, family, hemoglobin-A1c, family support, family interaction and 
communication 
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Problem Identification and Significance 
Types 1 and 2 diabetes mellitus (T1DM, T2DM) are among the top 10 causes of death in 
the United States (Qaseem, Humphrey, Sweet, Starkey, & Shekelle, 2012).  T2DM is one of the 
most common contributors to early morbidity and mortality in adults.  Every year, T2DM affects 
more than 70 million people in the United States and even more worldwide (Centers for Disease 
Control and Prevention, 2015).  In the United States it is reported that T2DM costs 
approximately $174 billion annually, and worldwide the cost of all diabetes classifications is 
approaching $548 billion (Lee, Saravanan, Varadhan, Morrissey, & Patel, 2014).  T2DM affects 
males and females equally (Chaufan, Davis & Constantino, 2011).  While T2DM affects 
individuals in all populations, certain groups such as African Americans, Hispanics, Asians, 
Pacific Islanders, American Indians, and Alaskan Natives are more likely to develop T2DM 
(Jack, Jack & Hayes, 2012; Komar-Samardjiza, Braun, Keithley, & Quinn, 2012).  
Factors contributing to T2DM include but are not limited to obesity, sedentary lifestyle, 
family history, glucose intolerance, and history of gestational diabetes (Mansyur, Rustveld, 
Nash, & Jibaja-Weiss, 2015; Scollan-Koliopoulos, 2004; Williamson, Vinicor, Bowman, & 
Centers for Disease Control and Prevention Primary Prevention Working Group, 2004).  
Macrovascular and microvascular changes associated with T2DM lead to co-morbidities, 
decreased health status, and death (Qaseem et al., 2012).  Individuals with T2DM need family 
support to deal with the complexity and management of this disease (Rosland, Heisler, Choi, 
Silveira, & Piette, 2010; Mansyur et al, 2015).  
Importance of Family Support in Disease Management 
Effective communication is the cornerstone of successful relationships. When families 
are faced with stressors, they often turn to each other to maintain the family unit (Paddison, 
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2010).  If the family unit is able to effectively communicate, the family is likely to be successful 
in dealing with the stressor, T2DM and offering support. However, multiple variables affect a 
family’s ability to communicate and support each other during times of stress, as is the case with 
T2DM. For example, when a family member has T2DM, family communication is often 
challenged and/or disrupted, and such a challenge often leads to disruption in the family unit.  
Simple, positive encouragement can be used to effectively communicate with and support 
the family member with T2DM.  For example, one strategy to help the family positively 
communicate and support a family member with T2DM is to help the patient maintain a proper 
diet and adhere to a medication regimen (Rosland et al., 2010; Satir, 1967).  Successful 
interaction and communication within the family unit facilitates self-management for individuals 
with T2DM by encouraging them to participate in their own care.  Rosland et al. (2010) found 
that when the family unit is supportive and active in the day-to-day care of the patient with 
T2DM, the patient takes a more active role in adherence and management of T2DM.  This 
facilitates better outcomes and results in fewer long-term complications (Rosland et al, 2010).   
In this DNP final project, the Family Communication Model (Satir, 1967) was used to 
help identify lack of communication that occurs within a family when a member has T2DM and 
to create an evidence-based educational intervention in a primary care practice setting to improve 
communication patterns for the patient and family and enhancing family support.  By using the 
Family Communication Model, primary care providers can help family units to communicate 
and interact more positively.   
The Family Communication Model can be used to foster and facilitate active dialogue 
between and among family members in a positive way and to enhance the delivery of accurate 
messages.  This allows the family unit to communicate in a positive, effective manner; reduces 
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anger and confusion; and increases positive interactions among the family unit. Researchers have 
demonstrated that such family support is essential to help the patient with T2DM to adhere to 
treatment plans, manage the disease, and promote long-term, positive outcomes (Rosland et al., 
2010).  Satir’s Family Communication Model provides an excellent framework for nurse 
practitioners working in primary care settings to facilitate family communication and enhance 
outcomes for patients with T2DM.   
Riverside Medical Group-Jersey City Palisades, located in northern New Jersey, is a 
primary care setting.  Approximately 40% of the adult patient population has been diagnosed 
with T2DM.  The majority of this population is of Hispanic or Indian descent (40% and 25% 
respectively); 15% are White, 15% are African American and 5% are other. The health care 
providers in the Riverside Medical Group-Jersey City Palisades attempt to educate patients with 
T2DM at every encounter; however, most patients are not health literate, specifically regarding 
healthy diet.  Despite provider efforts, patients in this group continue to base their diets on 
cultural preferences.  It is important that once education is provided in the clinical setting it is 
implemented at home.  Education and support regarding proper diet and exercise or medication 
regimen for the patient with T2MD must be reinforced in a positive manner to promote disease 
management.   
Literature Review  
The databases CINAHL, MedScape, and Cochrane Library were among the databases 
searched for studies written in English and published in scholarly journals between 2010 and 
2015. Search terms included the following: diabetes mellitus type 2, non-insulin dependent 
diabetes mellitus, diabetes mellitus, adult onset, diabetes mellitus, noninsulin-dependent, 
diabetes mellitus, type II, evidence-based practice, glycemic control and primary care, family 
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guidelines, family support and communication, family interaction, and glycemic index. 
Approximately 500 articles met these initial inclusion criteria. Next, articles were excluded if 
they were not peer-reviewed, involved patients under the age of 18, or discussed care of patients 
with T1DM or pre-diabetic patients.  Based on these results, 50 articles were available for review 
and 20 of the most relevant were used in this project.  The table included in this final DNP 
project includes seven of these articles.   
Appraisal of Evidence 
The results of the review were organized based on the key constructs driving this study: 
family support and self-management of T2DM.  The literature was reviewed for evidence of the 
relationship between family support and communication and disease management outcomes of 
patients with T2DM. 
 The current literature demonstrates the importance of family support through highly 
effective communication (Lewin et al., 2010).  However, few researchers have specifically 
assessed the effect of family support on disease management and outcomes for competent 
patients living with T2DM (Rosland et al., 2010).  Rosland et al. (2010) described a competent 
patient as a mentally stable person able to care for him or herself without outside support.  These 
authors identified barriers to family support and communication that hindered management of 
glycemic control by individuals with T2DM.  
Barriers may be encountered when a family member refuses to comply with the same diet 
as the patient, does not support timely administration of medications, or causes embarrassment 
about self-care measures (Rosland et al., 2010). If the family member with T2DM does not feel 
supported, simple tasks, such as taking medications and following a diet, may be neglected.  
While the role of positive social support such as when the family supports the self-care of a 
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T2DM patient (Rosland et al., 2010) has been extensively studied, the effect of negative support 
has not been as thoroughly addressed in the literature.  Examples of negative support include 
complete lack of communication, inability to properly convey a message in a supportive fashion 
and lack of interest in the material being discussed (Rosland et al., 2010; Satir, 1967).   
Rosland et al. (2010) further described the increased stress that T2DM places on the 
family as whole as well as individual family members.  For example, changes to schedules, 
concerns about family members, and fear of hospitalization can stress the family unit. Paddison 
(2010) similarly found that stress caused by the family unit could increase stress hormones and 
negatively affect the patient’s systemic glucose. Family members can assist the patient in 
managing medications and eating a nutritious, glycemic balanced diet. Scollan-Koliopoulos and 
Walker (2009) concluded that successful interventions should focus on how the patient feels 
about the condition, allow the patient to express feelings and concerns, and provide guidance for 
families regarding health strategies to assist the patient.  
Family support 
In a cross-sectional study, Karlsen, Oftedal, and Bru (2011) used the Diabetes Family 
Behavior Checklist to evaluate the effect of family support on T2DM. Participants included 425 
Norwegian adults, and the authors concluded that “poor glycemic control, more intensive 
diabetes treatment, long-disease duration, high number of diabetes related complications and 
increased BMI are all important indicators of diabetes-related strains” (Karlsen et al., 2011, p.  
392).  The authors also found that support from practitioners was as important as support from 
the family unit, and that greater family unit and practitioner support yielded less distress and 
greater glycemic control. These results directly correlate with those of another cross-sectional 
study in which Paddison (2010) concluded that family support provides emotional and practical 
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support.  Using the Diabetes Family Support and Conflict scale, the author noted that when the 
family assisted the patient with care (e.g., blood glucose testing, foot care, or identification of an 
oncoming hypoglycemic episode), the patient had a better outcome.  
Paddison (2010) and Scollan-Koliopoulos and Walker (2009) found that stress in a family 
unit could potentially compromise physiologic glycemic control, and that poor inter-family 
communication and function could interfere with diabetes self-management (Paddison, 2010). 
The perspective of the family on disease pathology and progression also played a role in patient 
outcomes, and the diagnosis of diabetes in previous generations increased the understanding of 
the need for self-care behaviors and dietary control in the current population (Scollan-
Koliopoulos & Walker, 2009).   
In a qualitative interview study, Ahlin and Billhult (2011) identified specific needs for 
families that were working with members of older generations.  Ten women over the age of 65 
were interviewed, and five common themes were noted: ambiguous feeling of others’ 
involvement, becoming a victim of pressurizing demands, experiencing knowledge deficits, 
experiencing an urge and finding reasons to justify not changing (Ahlin & Billhult, 2011, pg. 
41).  Two Women in the Rosland et al study (2010) reported less family support than men (64% 
vs. 77%), and family barriers were associated with lower levels of self-care (p< 0.01).  The 
authors concluded that when older women are prescribed self-care, short-term interventions 
should address common themes to help them make on-going improvements to that self-care.    
 Self-care 
Family members provide crucial support to the patient that facilitates self-care.  Increased 
adherence to diabetic diets, treatment, and other self-care modalities were linked with adequate 
functioning of the family unit (California Medi-Cal Type 2 Diabetes Study Group, 2004; 
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Scollan-Koliopoulos, 2004).  When a family unit is dysfunctional or not working optimally to 
correct the behavior of the patient with T2DM, the family and patient are negatively affected.  In 
a descriptive, qualitative study, Lundberg and Thrakul (2012) evaluated self-management in a 
population of Thai Buddhists and found that family support was exceptionally important in the 
self-management of diabetes in this population.  Interestingly, in families with multiple diabetic 
patients, Scollan-Koliopoulos (2004) noted the potential for greater support since family 
members can empathize with each other  
Family members can help to control the disease and to support the patient mentally, 
emotionally, and fiscally.  However, factors such as culture, fiscal stability and religion were also 
addressed and despite self-management capabilities, poor glucose control was still present over 
all populations (Ahlin & Billhult, 2001; Lungberg and Thrakul, 2012).  Low health literacy, 
marital status, and family function also negatively influenced self-control of T2DM (Paddson, 
2010; Rosland et al., 2010). Such results demonstrate that despite appropriate family support, 
and patient-specific factors can negatively influence glycemic control.   
Link between Relevant Literature and this Project  
The results of these studies show the importance of family support for the adult with 
T2DM, and common features of such support included family involvement, effective 
communication patterns, and support for self-care.  Despite different focuses on gender or 
religion, for example, all literature reviewed statistically demonstrated that support from the 
family improved glycemic control in the patient with T2DM.   
Most of the studies included in this review were qualitative rather than quantitative, with 
a noticeable lack of randomized controlled trials and other studies with a high level of evidence. 
The nature of qualitative inquiry may be more useful to capture the perceptions and impressions 
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of participants.  Most of the studies included specific populations, such as women, Hispanics, 
and Thai Buddhists.  Appendix 1 provides a summary of the most relevant articles in the 
literature review and their levels of evidence.   
 
Purpose and Clinical Question 
The purpose of this evidence-based, DNP final project was to evaluate the effect of 
family support on adults with T2DM as measured by outcomes related to serum hemoglobin-A1c 
(HbA1c) test results during a three-month period from February 12, 2016 to May 12, 2016.   
Study Focus  
Because the family unit forms the basis of communication and social interaction (Satir, 
1967), the focus of this study was the support of patients with T2DM by their family members. 
Patients with T2DM and their families often become stressed by the diagnosis and management 
of T2DM, and this stress negatively affects their ability to communicate effectively as a family 
unit.  Such communication is essential for the provision of meaningful support.  The 
development of coping skills begins within the context of the family (Lewin et al., 2010).  
Aims and Objectives 
The overall objective of this DNP final project was to assess the influence of family 
support on glycemic control by measuring HbA1c to determine whether a statistically significant 
change in HbA1c existed post intervention. Family support was defined as the influence of the 
primary support person (blood-relative, marriage relative, or anyone filling this role as defined 
by the patient) who directly assists the patient with self-care (Rosland et al., 2010).  The 
secondary objective was to identify barriers to effective family support. Hypothesis one for this 
DNP final project was that positive family support facilitates positive outcomes in patients with 
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T2DM. Hypothesis two is that tailoring an educational intervention in a primary care setting for 
patients and family members will enhance glycemic control. Hypothesis three is that Satir’s 
Family Communication Model would enhance family dynamics and communication between 
family members and the patient with T2DM. 
Methods/Implementation 
Design  
A prospective cohort design was used because this methodology is well-suited to 
establish a link between potential problems and expected outcomes among individuals who share 
a common trait (Song & Chung, 2010).  The common trait in this DNP final project is that family 
support positively influences the glycemic control of the T2DM patient.  The cohort design 
allowed us to determine whether one particular variable (family support) influenced the outcome 
(glycemic control) in the study population (self-care adults with T2DM) (Campbell, Machin, & 
Walters, 2007; Song & Chung, 2010).  The research design included a control and intervention 
group, and assignment to the control and intervention groups was randomized.  The control 
group received routine counseling and encouragement as per the current standards of care in 
Riverside Medical Group.  The intervention group received increased, tailored, family-focused 
education based on the Satir (1967) Family Communication Model. The level of significance for 
the study was set at p ≤ 0.01.   
The sub-investigator administered a pre and post-intervention survey to assess the 
dynamics and interactions of the family.  There was a specific focus on the person who was most 
influential to the patient from the patient’s perspective.  For example, the person mostly likely to 
influence, either positively or negatively the T2DM patient such as a significant other, close 
friend or someone involved in the daily life of the T2DM patient.  The pre- and post-intervention 
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survey consisted of a 42-question Likert scale survey, the Family Support for Self-Management 
scale (FSSMS): Rosland et al. (2010).  The FSSMS is a valid and reliable measurement 
instrument used to evaluate how well the family supports the diet, medication regimen, medical 
follow up, and exercise of the patient with T2DM.  
The sub-investigator investigator recruited participants, and after they provided written 
and verbal consent, they were given the study materials.  Surveys were distributed at the 
beginning of the study when the first HbA1c was obtained by the sub-investigator from the 
patient’s chart; surveys were again distributed the conclusion of the study. The surveys were 
completed by the participants and placed in a sealed envelope and returned to the sub-
investigator.  The materials were coded for anonymity and only the sub-investigator investigator 
had access to the master list of participants.  The intervention and control groups were 
randomized so that even-numbered surveys were the control group while odd-numbered surveys 
were the intervention group. Data were entered in Statistical Package for the Social Sciences 
(SSPS), version 24, and only the sub-investigator had access.   
Theoretical Framework 
This study was based on the Family Communication Model proposed by Virginia Satir 
(1967).  This model focuses on the direct and indirect communication that occurs among families 
under stress. Satir reported that by learning about our internal workings families could change 
the outgoing social message and allow for self-growth to better relate to others and ourselves. 
Satir described the family’s verbal and non-verbal cues to each other as interactions that can 
convey powerful messages and posited that for the family to communicate clearly, there must be 
respect of the other person’s self-worth (Satir, 1967).  Clear and effective communication is 
necessary for positive support. In relation to T2DM care for example, if a family member eats 
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foods that are not approved for the patient, he or she sends strong non-verbal communication that 
such foods are appropriate therefore the patient’s needs are not respected.   
In order to establish effective communication, Satir proposed Five Freedoms: (a) the 
freedom to see and hear what is here, instead of what “should” be, was, or will be; (b) the 
freedom to say what you feel and think, instead of what you “should” feel and think; (c) the 
freedom to feel what you feel, instead of what you “ought” to feel; (d) the freedom to ask for 
what you want, instead of always waiting for permission; and (e) the freedom to take risks on 
you own behalf, instead of choosing to be only “secure” (Satir, 1967, pg. 62).  Use of Satir’s 
Five Freedoms can be an effective means to increase the quality of family dynamics, enhance 
communication, and facilitate family support.     
Patients with diabetes rely upon support from family members to control their behavior.  
Verbal and non-verbal communication must remain effective and appropriate so that the patient 
can maintain glycemic control.  However, it is sometimes difficult to establish the difference 
between positive and negative support. People can become defensive when they perceive an 
insult or criticism, especially when unsolicited. If patient becomes defensive, he or she is less 
receptive to constructive criticism and is more likely to rebel.  This can result in poor 
relationships, impair communication patterns, and significantly decrease the patient’s glycemic 
control.  
During the intervention, it was anecdotally noted that family members perceived that any 
interest shown to the family member with T2DM was positive.  The investigators used the Five 
Freedoms to demonstrate the importance of allowing participants to speak their minds to develop 
more positive communication patterns.   
Participants 
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The participants for this study were randomly selected via convenience sampling by the 
sub-investigator. The inclusion criteria for the study included the following: diagnosis of T2DM 
for at least six months, patients of Riverside Medical Group-Jersey City Palisades office, ability 
to understand English, older than the age of 18, and availability of family locally (defined as a 
specific person who was able and willing to assist in care). Participants were excluded if they 
were not able to speak English as determined by the patient’s proficiency in conversation with 
the investigators, were not diagnosed with T2DM, or were less than 18 years old. Exclusion 
criteria also included diagnosis of T1DM, glucose intolerance, mental disorders that precluded 
the patient from taking an active role treatment, no family support, and a hemoglobin-A1c so 
elevated that initiation of new medication or a change in dosage of current medication was 
required.  The type of therapy, be it non-pharmacological, oral or injectable therapy, such as 
Glucophage, Liraglutide, insulin, or any other medication therapy for T2DM did not disqualify 
potential participants. 
The investigators recruited a sample size of 10 participants in the intervention and control 
groups for a total sample of 20 to ensure statistical significance.  The electronic medical record 
(EMR) had the ability to identify all patients that met inclusion criteria.  Based on information in 
the EMR, potential participants were recruited by a flyer approved by the Drexel Institutional 
Review Board that was posted at the front desk of the office.  Participants were also actively 
recruited by office staff but further screened and consented by the sub-investigator.   
Human participants protection 
Institutional Review Board (IRB) approval was obtained from Drexel University.  All data 
collected during the course of this study was kept private and secured.  There were no names or 
any participant identifiers on the survey except the numerical coding which only the 
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investigators had access to the master list.  All completed surveys were securely stored, and data 
was entered into a computer system that was password protected and encrypted.  All materials 
will be destroyed one year after completion of this study.  The sub-investigator obtained final 
consent from all participants, and the consent document can be found in Appendix 2.   
Setting and Resources 
The setting for this study was Riverside Medical Group-Jersey City Palisades. The Chief 
Medical Officer of Riverside Medical Group was made aware of the background, focus, goals, 
and risk and benefit profile of the study. This practice offers primary care services to patients of 
all ages and serves a large number of patients from diverse ethnicities, cultures, religions, and 
socioeconomic statuses. The practice has approximately 200,000 visits per year from 
approximately 70,000 families in Northern New Jersey.  The study location has approximately 
200-250 T2DM care visits monthly that account for one-third of all monthly visits.  
Measures   
The sub-investigator, a provider at the study site, initiated the study when the HbA1c was 
collected for the first time and concluded the study when the final HbA1c was collected three 
months later. The pre-intervention HbA1c was assessed from the patient’s chart or drawn at the 
initiation of the study to test for baseline T2DM control.  The HbA1c results were obtained from 
the patient’s chart, so there were no extra costs for participation. If the HbA1c was not part of the 
patient’s chart it was offered as part of normal level of care that would be covered by the 
patient’s insurance.  If the insurance did not cover the cost of the serological examination, the 
participant had the option of paying for the test or withdrawing from the study.   
After 12 weeks, participants that were still in the study had follow up HbA1c tests. To 
evaluate for statistical significance, the analysis of covariance (ANCOVA) test was utilized. The 
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ANCOVA test was determined to be the best for a pretest-posttest cohort design because it can 
be used to confer greater statistical power and to correct for regression to the mean (Tay et al., 
2014).  The resulting statistics were used to demonstrate whether family support has positive or 
negative influence on patients with T2DM. 
A pre- and post-intervention survey, the FSSMS, was used to measure family structure and 
function and family support for self-management of T2DM based on five domains: healthy 
eating, exercise, self-testing, medications and general information/decisions (Rosland et al., 
2010).  The FSSMS consists of 42 questions with five possible answers that range from never to 
almost every day.  This survey was provided to the participants at the beginning and end of the 
study.  The scale has a Cronbach’s alpha score of 0.82 that indicates high internal consistency 
and reliability and validity.  Appendix 3 contains the permission from Dr. Rosland for use of the 
tool; Appendix 4 is the actual FSSMS.   
Procedures 
The project was implemented based on the Plan, Do, Study, Act (PDSA) method created 
by Deming (1951). The PDSA method utilizes a systematic approach to continually improve a 
learning process. Objectives are identified (Plan), the plan is implemented (Do), the outcomes 
are analyzed and evaluated (Study), and a decision regarding implementation or revision is made 
(Act) (Craig & Smyth, 2012; W. Edwards Deming Institute, 2016). 
A flyer was posted in the front of the office alerting patients to the study.  The sub-
investigator had access to records of the patient roster at the study site and was responsible for 
participant recruitment. The study included a control group that received the normal care and 
counseling following routine diabetic protocols and an intervention group that received tailored 
education counseling with special attention paid to education of the family regarding the 
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provision of support to the T2DM patient and the role of the family in glycemic control. The sub-
investigator created teaching points for the participants and families: 
1. Allow each other to be heard. 
2. The tone and inflection is as important as the wording. 
3. Support that is meant to be positive can be misconstrued as insulting or negative. 
4. Recognize body language. 
5. Recognize when it is not an appropriate time to offer aid or criticism. 
6. Be open to aid, support, and criticism; it does not mean you are weak. 
7. Allow yourself to be pushed from your comfort zone. 
Timeline 
The study was completed in three months (February 12, 2016 to May 12, 2016) because 
three months must elapse before the hemoglobin-A1c serology examination is valid.  While there 
was only a need for participants to come in for direct face-to-face evaluation at the 
commencement and conclusion of the study, the lessons learned about family support were 
continued at home during the study timeline.  Participants were offered the opportunity to return 
to the office for further reinforcement of these behaviors on an as-needed basis.   
Evaluation  
Data analysis was completed using SPSS version 24.  Descriptive and inferential 
statistics were used to describe the primary study variables, and correlation coefficients were 
used to describe relationships between primary study variables.  Nominal level data were 
measured by descriptive statistics: frequency distribution, range, and mode.  Any missing data, 
such as questions left unanswered, were coded 99 to demonstrate missing status.  Questions that 
were not applicable to the participant were coded 88.  This most commonly occurred with the 
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items does your family help check your glucose and does your family help you administer your 
insulin. The final study material was assessed and evaluated by the sub-investigator with the 
assistance of the primary investigator.   
Since this was an association and strength of relationship study using a nonparametric 
format, an ANCOVA test was used to test for a correlation between the variables.  The 
ANCOVA test also is able to remove extraneous variables and to focus on linear regression 
between the primary variables (Campbell et al., 2007).  A biostatistician assisted with data 
cleaning and analysis. 
The level of significance was set at p ≤ 0.01, which reflects a pilot study design, as this 
was a pilot study completed in a single practice in a localized area.   
Outcomes 
The outcome measures for this study were HbA1c levels and results on the FSSMS 
demonstrating participant satisfaction of their family support. HbA1c levels were collected to 
establish baseline and then three months later to evaluate post-intervention glycemic control.  
The survey results were used to evaluate patient perceptions of family support. A biostatistician 
used a mixed model analysis in SPSS 24 to aid in data analysis.  The initial analysis did not 
include the participant’s perception of family support, so the SPSS spreadsheet was reformatted 
to include the sum total and average of the scores from the Likert scale.  If the patient indicated a 
question was not applicable or left the question blank, the 88 or 99 that was initially placed was 
removed and the sum and average were recalculated excluding the missing data. 
No statistical significance was found in HbA1c levels between the intervention and 
control groups.  There was a marginally significant positive negative correlation in HbA1c levels 
in the intervention group noted at the 3-month interval.  In the intervention group, the data from 
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the FSSMS demonstrated a decrease in family support at the conclusion of the study and the 
intervention group had less family support at the conclusion of the study than the control group.  
Results 
Participant Demographics 
 Responses were analyzed with descriptive statistics, and relationships were examined 
using correlation coefficients.  Detailed demographic data for the participants are provided in 
Table 1. Participants were mostly female (65%), their average age was 53 years (range 37-75 
years), and they were mostly Hispanic or African-American.  Some participants had T2DM for 
many years, but some had it less than a year.    
Medication regimens varied among participants, and medication therapy was not titrated 
during this study, as the focus was to evaluate a change in glycemic control with just family 
support education. In this group, oral medication was the primary class of hypoglycemic therapy.   
The range and average for the HbA1c remained the same from the beginning to the end of the 
project.  This lack of change in the overall average indicates that the intervention had no 
statistically significant effect on glycemic control.  For both groups, an approximate 0.5% 
decrease was noted in HbA1C post-intervention, with changes of -3.7% to + 2.2%.  
Comparison of Groups Pre- and Post-intervention  
A total of 20 pre-intervention surveys were distributed by the sub-investigator to the 
study sample, and 19 were returned, yielding a return rate of 95%. The post-intervention 
response rate was 45% with nine of 20 surveys returned. The final sample size was nine.    
` Nine participants completed the entire study, five in the control group and four in the 
intervention group.  All participants in the intervention group had a drop in HbA1c, which 
contrasts to a wide range of changes, positive and negative, in the control group at the 
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completion of the study.  The change in HbA1c post-intervention was control: HbA1c ranged 
from – 3.7% to + 2.2%.  Intervention: HbA1c ranged from -0.2%- to -0.7%.  This wide range of 
average HbA1c can possibly be attributed to personal problems not controlled for in this study or 
not being subjected to the intervention.  Another potential reason for such a large range in the 
control group was that there was a higher average starting HbA1c.  The conclusion HbA1c noted 
an overall change of -0.5% for both control and intervention groups.   
Table 2 represents that data at the beginning (timepoint) and end (intervention) of the 
study and where they compare (timepoint x intervention).  The significance at each level was 
greater than the level of significance, which for this final DNP project was p≤ 0.01.  
 Completion of ANCOVA testing demonstrated no statistically significant difference in 
patient HbA1c levels between the intervention and control groups. The majority of the 
participants, male and female reported that their families take an active role in their care.  
Respondents reported positive support such as, “my sister helps me cook and take my 
medications” and “my family reminds me to take my medications.”  Two respondents noted 
negative support: “I have to care for others, not the other way around” and “My family does not 
support me.”   
An ANCOVA test of significance was chosen to test relationships that existed in the data 
and a non-parametric design was utilized because of the low sample size and the use of nominal 
level of measurement.  There was no positive statistical correlation between family support and 
glycemic control. There was no statistically significant difference between the control and 
intervention at baseline for family support or HbA1c and at three months the intervention group 
indicates a decrease in family support.   
Support/nonsupport of hypotheses 
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 The data indicated no statistically significant relationship between family support and 
glycemic control.  The significance of the data at the time end of the study was found to be 
0.559, which is greater than the p value of 0.01 indicating that the hypothesis should be rejected.  
The biostatistician stated that the analysis of the data could be altered due to artifact from 
measurement error.  The data also suggests that hypothesis 2 tailoring education interventions in 
a primary care setting for T2DM patient did not significantly enhance glycemic control.  It was 
also demonstrated that hypothesis 3, Satir’s Family Communication Model would enhance 
family dynamics and communication should be rejected as well.   
Discussion 
 The results indicate that some participants with T2DM had decreased HbA1c 
levels.  However, this change cannot be attributed to family support. In fact, in the intervention 
group, family support trended down instead of up after the intervention. One participant had a + 
2.2% increase in HbA1c and reported that her family was initially involved in her care then 
stopped.  The participant with a negative 3.7% change reported strong family support from his 
wife and co-workers who strongly urged him to eat better, exercise, and take his medications.  
Another significant study limitation is that this study lacked control over extraneous variables, 
such as significant life events, and did not have protocols in place for life events, for example, 
births, deaths, marriage or divorce.   
This large variation of HbA1c values post-intervention could be related to significant 
family support versus no family support.  There could also be extraneous factors such as 
significant family events, or participant’s noncompliance in their self-care.  This indicates that 
the hypothesis is to be rejected and the theory of the study lacks statistical significance.  Utilizing 
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the PDSA method, the hypothesis and method of this DNP final project would be reworked and 
reattempted in an effort to obtain statistical significance in a future study.   
Relationship to Previous Studies 
 Since results did not reach statistical significance, they to do not support previous studies 
that demonstrated a positive relationship between family support and glycemic control.  Overall, 
HbA1c values indicated a positive negative correlation, indicating increased glycemic control at 
the end of the study.  A plausible explanation for this positive negative correlation could be 
attributed to factors and extraneous variables not controlled for by the research methods.  
 It was demonstrated in this study that significant family stressors and lack of family 
support negatively influences glycemic control.  There were no religious or cultural influences 
reported by any participants.  The participants noted the largest increase in glycemic control 
when family was directly involved with day-to-day care. For example, aid in food preparation, 
medication management, actively supporting self-care and providing support instead of criticism.   
Limitations 
 Small sample size and from one location is a limitation of this final DNP project.  Other 
limitations included unreturned FSSMS measurement tools, incomplete data on the FSSMS 
measurement tool, lack of participant clarity and understanding on how to respond to questions 
on the FSSMS measurement tool.  
Conclusions and Implications 
Analysis and Discussion 
The sub-investigator assisted by Dr. Jandell Mensinger, a trained biostatistician, 
completed data analysis.  Once the pre and post-intervention data was collected the sub-
investigator imputed all information into a password-protected, encrypted computer.  Dr. 
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Mensinger offered insight into the proper preparation of the data for analysis, for example, 
cleaning the data and formulating proper SPSS data organization techniques.  Mixed Model 
Analysis of the ANCOVA statistical testing analysis tool was completed by Dr. Mensinger.  
Discussion on its implication and meaning was a collaborative effort by Dr. Mensinger and the 
sub-investigator.  At all points of data analysis, the value was above </= 0.01 the p value for this 
final DNP project resulting in the rejection of all hypotheses.   
The resulting analysis indicates that there is no statistically significant difference in 
glycemic control in a patient with T2DM when patient education is focused on an education 
intervention that takes family support into account.   
Findings and Clinical Implications 
This study has potential relevance for all primary care providers, including nurse 
practitioners.  The identification and provision of appropriate patient support can increase 
medication and diet adherence and reduce morbidity and mortality.  This study allowed for an 
examination of the patient’s perception of the family support structure in relation to self-care 
behavior.  Correct assessment of how the patient perceives family support is a significant 
component to enhancing patient education and family support for a patient with T2DM.  For 
example, if the patient believes they are being prosecuted instead of helped they can self-harm 
instead of self-care.   
From a societal perspective, increasing glycemic control for a patient with T2DM is 
paramount in decreasing overall cost to the health care system in care of patients with chronic 
T2DM.  Health care systems are strained fiscally, and diabetes is one of the main contributors to 
elevated health care costs in chronic disease care and management.  Enhancing the 
communication patterns, understanding family dynamics and improving overall support tools in 
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the care of patients with T2DM has great potential for better understanding the complexities and 
challenges in care of the patient with T2DM. 
Family support is important in the care of all patients, and this is especially true for 
patients with T2DM.  The literature clearly indicates that patients with positively involved 
families have better compliance with medication regimens and decreased morbidity and 
mortality, and the purpose of this study was to evaluate the inter-family relationship. 
Conclusion 
 Patients with T2DM participating in this DNP final project anecdotally reported feeling 
positive about the project had positive outcomes. Support for patients with T2DM must be 
continually reinforced in order to help the patient, gain glycemic control and minimize untoward 
disease outcomes.  T2DM is a chronic disease with major untoward outcomes on multiple body 
systems and end-organ demise.  Further research is needed in this important area of primary care 
practice to better understand and offer support for interventions that improve patient glycemic 
control and better disease management.   
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Table 1. Demographic Data for Participants (N =9) 
Average Age 53 years 













N=1  11% 
N=3  33% 
N=4 44% 
N=1  11% 
Average duration of T2DM diagnosis  8.54 years, range 0.33 to 25 years 
Medication for glycemic control 











8.5% range 6.3%-13.7% 
8.5% range 6.0%-13.7%  




9.98% range: 6.9-12.7% 
9.48% range: 6.4 13.7% 




8.95% range: 6.4-13.7% 
8.48% range: .6.0-13% 
Note. T2DM = type 2 diabetes mellitus.  
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Table 2. Inferential Statistics: ACNOVA Testing for Fixed Effect 
Source Numerator df Denominator df F Sig. 
Intercept 1 19.068 136.372 0.000 
Timepoint 1 9.140 0.024 0.881 
Intervention 1 19.068 2.401 0.138 
Timepoint* 
intervention 
1 9.140 0.367 0.559 
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Appendix 2. Introduction Letter to Participant/Staff and Passive, Informed Consent Drexel 
University  
 
A. Consent to Take Part in a Research Study  
 
1. Title of Research Study 
 




Dr. Carol Patton, Primary Investigator 
Craig Sorkin, MSN, APN, Sub-investigator 
3. Why you are being invited to take part in a research study? 
 
We invite you to take part in a research study because of your diagnosis of Diabetes Mellitus 
Type 2 (T2DM).   
4. What you should know about the research study? 
This study and its effects and hopeful outcome will be explained in full to you.  You have the 
choice to participate or not without consequences or changes in your current medication regimen 
and follow up.  If you choose to take part in this study, you have the ability to withdraw at any 
time without consequence.  
Please feel free to ask any questions about the study, its potential benefits, and possible 
negative effects.   
5. Who can you talk to about this research study? 
If you have questions, concerns, or complaints, or think the research has hurt you, talk to 
the research team cis34@drexel.edu or cmp358@drexel.edu.  
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This research has been reviewed and approved by an Institutional Review Board (IRB). An 
IRB reviews research projects so that steps are taken to protect the rights and welfare of human 
participants taking part in research.  You may talk to them at (215) 255-7857 or email 
HRPP@drexel.edu for any of the following: 
 Your questions, concerns, or complaints are not being answered by the research team. 
 You cannot reach the research team. 
 You want to talk to someone besides the research team. 
 You have questions about your rights as a research participant. 
 You want to get information or provide input about this research. 
 
6. Why are we doing this research? 
Diabetes mellitus type 2 (T2DM) causes significant morbidity and mortality.  Family 
support is paramount in controlling the negative effects of T2DM.  By having family assistance 
you increase your ability to control your glucose, decrease your hemoglobin-A1c, increase your 
health, and strengthen family interactions.   
7. How long will the research last? 
We expect that you will be in this research study for a period of three months.  While there 
is only a requirement of meeting with the research team and the beginning and end of the study, 
it is encouraged to continue the education about family support in the interim period to increase 
glycemic control.   
8. How many people will be studied? 
We expect about 20 people here will be in this research study. 
9. What happens if I say yes, I want to be in this research? 
 
 This study will take place over three months. 
 Visits will last approximately 15-20 minutes. 
 The sub-investigator and contact person is Craig Sorkin, APN, who will collect all 
consents, data, and provide the intervention. 
Running head: FAMILY INFLUENCE ON GLYCEMIC CONTROL  39 
 
 
 All study intervention education will occur at Riverside Medical Group-Jersey City 
Palisades. 
 While the active intervention education will occur during the time with the sub-
investigator, participants will be encouraged to continue the lessons learned at home to 
improve their glycemic control.  
 Assessment and evaluation of the effect of family support on T2DM will be examined 
during this study timeline. 
 Family support, modification of medication regimen, and full and proper care of diabetes 
will be provided despite participation or lack of participation in this study. 
 Regardless of your participation in this study, family support will be encouraged. 
 Further studies may be completed based upon the results of this study. 
 
10. What are my responsibilities if I take part in this research? 
If you take part in this research, it is very important that you 
 Follow your physician or researcher’s instructions. 
 Tell your study physician or researcher right away if you have a complication or injury. 
 Actively participate in the family interaction education.  
 Encourage family to participate in your care 
 
11. What happens if I do not want to be in this research? 
You may decide not to take part in the research and it will not be held against you. The 
important risks and possible benefits of these alternatives are listed below. Participation in this 
study may help you get better control of your T2DM. 
 
12. What happens if I say yes, but I change my mind later? 
You agree to take part in the research now and stop at any time it will not be held against 
you. 
If you decide to leave the research, you will be returned to previous level of care where you 
will be provided support, medication management, and care for your T2DM.  If you decide to 
leave the research, contact the researcher so that the researcher can remove your information 
from the study materials.  
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13. Is there any way being in this study could be bad for me? 
There may be family dynamic changes that occur during this study as the study parameters 
include changing family interactions.  The sub-investigator will be there to demonstrate and 
support positive changes in family interaction.   
14. Do I have to pay for anything while I am on this study? 
There is no cost to you for participating in this study above any co-payments required for 
normal visits.   
This study will only involve reviewing your medical records.  No additional procedures or 
medicine will be given to you.   
You will not be charged for any tests specifically required for this research study, but you 
or your insurance company will be billed for tests or procedures that are considered “standard of 
care” and would have been part of your medical treatment if you did not participate in this study. 
These treatment costs include but are not limited to drugs, routine laboratory tests, x-rays, scans, 
surgeries, routine medical care, and physician charges.   
Your health insurance company may not pay for these “standard of care” charges because you 
are in a research study.  If your insurance company does not pay for costs associated with this 
research study that are considered standard care for your medical treatment, then you will be 
billed for these costs.  You are responsible for paying for any insurance co-pays and any 
deductibles due under your insurance policy, and any charges your insurance company does not 
pay.   
So that you do not have unexpected expenses from being in this study, ask your study 
doctor for a list of the tests or procedures that will be paid by the sponsor of the study.  
15. Will being in this study help me anyway? 
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We cannot promise any benefits to you or others from your taking part in this research. 
However, possible benefits include stricter control of your diabetes mellitus type 2.  
Benefits of participation include: stronger family communication, tighter glycemic control, 
and decreased risk of co-morbidities from diabetes and less financial burden as your diabetes is 
more controlled. 
16. What happens to the information we collect? 
Efforts will be made to limit your personal information, including research study and 
medical records, to people who have a need to review this information. We cannot promise 
complete secrecy. Organizations that may inspect and copy your information include the IRB 
and other representatives of this organization.  Riverside Medical Group will also have access to 
study materials, so as to change protocols for the future care of all Riverside Medical Group 
patients.   
17. Can I be removed from the research without my OK? 
The person in charge of the research study or the sponsor can remove you from the 
research study without your approval. Possible reasons for removal include changes to your 
medication regiment required to reduce hemoglobin-A1c.  This study is being utilized to identify 
familial influences on T2DM, not medication effects.  
We will tell you about any new information that may affect your health, welfare, or choice 
to stay in the research. 
18. What else do I need to know? 
Participation is voluntary and is being completed to improve your glycemic control.  
Results of this study may prove to service all diabetic patients at Riverside Medical Group.   
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If you become ill during this study, please contact Craig Sorkin, APN at telephone number. 
201-656-0001.  If you require immediate medical attention, you should go to the nearest 
emergency room or call 9-1-1.  It is important that you inform all emergency medical staff that 
you are participating in this study. 
 It is important for you to follow your physician’s instructions including notifying your 
study physician as soon as you are able of any complication or injuries that you experienced.  
You will not be paid for any other injury or illness-related costs, such as lost wages.  You 
are not waiving any legal rights by participating in this research study.   
Federal law provides additional protections of your personal information that are described 
here. 
B. Individually Identifiable Health Information That Will Be Collected 
 
The following personal health information about you will be collected and used during the 
research study and may be given out to others: 
 Your name, address, telephone number, date of birth; 
 Personal and family medical history; 
 Information from laboratory tests, blood and urine tests, x-rays, physical exams and 
other tests or procedures described in this consent form. 
 Information learned during telephone calls, surveys, questionnaires and office visits 
done as part of this research study; 
 Information in medical records located in your doctor’s office or at other medical 
facilities you may have received treatment. 
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 List any additional information that may be obtained from participants that is not 
covered by the activities and procedures listed in the Consent Form. Examples might 
include information about financial and social circumstances, or educational level. 
C. Who Will See and Use Your Health Information within Drexel University 
 
The researcher and other authorized individuals involved in the research study at Drexel 
University will see your health information during and may give out your health information 
during the research study. These include the researcher and the research staff, the institutional 
review board and their staff, legal counsel, research office and compliance staff, officers of the 
organization and other people who need to see the information in order to conduct the research 
study or make sure it is being done properly. Your health information may be disclosed or 
transmitted electronically. 
D. Who Else May See and Use your Health Information 
 
Other persons and organizations outside of Drexel University may see and use your health 
information during this research study. These include: Riverside Medical Group 
 Governmental entities that have the right to see or review your health information, such 
as The Office for Human Research Protections, and the Food and Drug Administration 
 Doctors and staff at the hospital where this research study will take place. 
 Doctors and staff at other places that are participating in the research study. 
 A data safety monitoring board. 
If your health information is given to someone not required by law to keep it confidential, 
then that information may no longer be protected, and may be used or given out without your 
permission. 
E. Why your health information will be used and given out 
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Your health information will be used and given out to carry out the research study and to 
evaluate the results of the study. If you do not want to give authorization to use your health 
information 
You do not have to give your authorization to use or give out your health information. 
However, if you do not give authorization, you cannot participate in this research study. 
F. How to cancel your authorization 
 
At any time, you may cancel your authorization to allow your health information to be used 
or given out by sending a written notice to Human Research Protection at 1601 Cherry Street, 3 
Parkway Bldg., Mail Stop 10-444, Philadelphia, Pennsylvania, 19102. If you leave this research 
study, no new health information about you will be gathered after you leave. However, 
information gathered before that date may be used or given out if it is needed for the research 
study or any follow-up. 
G. When your authorization ends 
Your authorization to use and give out health information will continue until you withdraw 
or cancel your authorization. 
After the research study is finished, your health information will be maintained in a 
research database. Drexel University shall not re-use or re-disclose the health information in this 
database for other purposes unless you give written authorization to do so. However, the Drexel 
University Institutional Review Board may permit other researchers to see and use your health 
information under adequate privacy safeguards. 
H. Your right to inspect your medical and research records 
 
You have the right to look at your medical records at any time during this research study. 
However, the researcher does not have to release research information to you if it is not part of 
your medical record. 
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You can have access to your medical record and any research study information when the 
study is over. However, the researcher does not have to release research information to you if it 
is not part of your medical record.  
Signature Block for Capable Adult 
Your signature documents your permission to take part in this research. 
DO NOT SIGN THIS FORM AFTER THIS DATE   
   
Signature of participant  Date 
 
 
Printed name of participant 
   
Signature of person obtaining consent  Date 
   
Printed name of person obtaining consent  Form Date 
 
My signature below documents that the information in the consent document and any other 
written information was accurately explained to, and apparently understood by, the participant, 
and that consent was freely given by the participant. 
   
Signature of witness to consent process  Date 
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Glad to help if I can.  Can you specify which topics/tools you are 
interested in?  In the cases where I used validated published tools they 
are referenced in the paper.  For some of the topics we wrote our own 
survey Qs. I could share them if they would be helpful, and could share 




Ann-Marie Rosland MD MS 
Assistant Professor, Division of General Internal Medicine, University of 
Michigan Medical School 
Research Investigator, Ann Arbor VA Center for Clinical Management Research 
https://sites.google.com/a/umich.edu/rosland_research/home 
 
For Research and Administrative Assistance: 
Contact Amy Lynn at lynnam@umich.edu or (734) 222-7621; Fax (734) 222-7182 
 
For Clinical Assistance: 
Contact the Ann Arbor VA Primary Care Clinic at (734) 845-5290; Fax (734) 
845-3225 
 
I am attaching the family support for self-management Qs from our survey. The APGAR is a published survey 
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Appendix 4. Family Support for Self-management Tool  
 
“Family” is defined in these questions as the individual(s) with whom you usually 
live.  If you live alone, consider family as those with whom you have the strongest 
emotional ties. 






I am satisfied that I can turn to my family for help when 
something is troubling me. 1
 2 3 
I am satisfied with the way my family talks over things with 
me and shares problems with me. 1
 2 3 
I am satisfied that my family accepts and supports my wishes 
to take on new activities or directions. 1
 2 3 
I am satisfied with the way my family expresses affection and 
responds to my emotions, such as anger, sorrow or love. 1
 2 3 
I am satisfied with the way my family and I share time 
together. 1
 2 3 
When people manage their diabetes, other people sometimes help and sometimes 
hinder them, no matter what their intentions may be. 
 
These questions are about people in your everyday life, such as family, friends and 
neighbors.  They do NOT refer to health care professionals (such as doctors, nurses, 
or health educators). 
Eating 
















Help you to buy healthy food or buy healthy food 
for you 1
 2 3 4 5  
Help you understand food nutrition labels 1 2 3 4 5  
Help you cook healthy food or cook healthy food 
for you 1
 2 3 4 5  
Help you to decide which things to eat at a meal 
or restaurant 1
 2 3 4 5  
Agree to eat at the same time that you need to 
eat 1
 2 3 4 5 88 
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Offer you healthy foods when you visit 1 2 3 4 5  


























Offer to exercise with you (for example, take a walk or 
go to an exercise class with you) 1
 2 3 4 5 
Change their schedule so that you can exercise 1 2 3 4 5 
Take care of your responsibilities (such as housework, 
caring for others) so you can exercise 
1 2 3 4 5 













Testing blood sugar 
I do not test my blood sugar         IF CHECKED SKIP TO C4 
 How often does a friend or family member:  









Help you remember to check your blood sugar 
1 2 3 4 5 
Help you plan when and where to check your 
blood sugar when you are not at home 1
 2 3 4 5 
Help you do your blood sugar testing 
1 2 3 4 5 
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Help you figure out what to do when your blood 
sugar test results change 1 2 3 4 5 
















I do not take any medications for diabetes   IF CHECKED SKIP TO C5 

















Help you remember to refill your medicines  
1 2 3 4 5  
Help you pick up your medicines from a 
pharmacy 1
 2 3 4 5  
Help you remember to take your medicines 
1 2 3 4 5  
Help draw up insulin or give you an insulin 
shot 1
 2 3 4 5 88 
Help you decide how much medicine to take 
or what time to take your medicine 1
 2 3 4 5 88 
Give you medications from their own supply 
1 2 3 4 5  













Information and Decisions 
 When you need help taking care of your diabetes how often does a friend or family 
member:  
 


















Give you information about managing diabetes 
1 2 3 4 5  
Share healthy recipes or information on healthy 
eating 1
 2 3 4 5 
 
Talk with you about their experiences or a 
friend’s experiences with diabetes 1
 2 3 4 5  
Help you notice that your health has changed 
1 2 3 4 5 88 
Help you decide what to do when you feel ill 
1 2 3 4 5 88 
Help you with low blood sugar symptoms 
1 2 3 4 5 88 
Overall, how often do other people try to help you                                                                                 












Help with Medical Care  
In these questions “Health Care Provider” refers to a doctor, nurse, nurse practitioner, or 
















Help you find or choose a health care provider 
1 2 3 4 5 
Help you schedule an appointment for a medical visit or 
test 1
 2 3 4 5 
Remind you to go to a medical appointment 
1 2 3 4 5 
Take you to a medical appointment 
1 2 3 4 5 
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Help you decide when to call your health care provider 
1 2 3 4 5 
Suggest questions to ask your health care provider 
1 2 3 4 5 
Help you figure out how your insurance coverage works 
1 2 3 4 5 
Pay for your health care with their own money 
1 2 3 4 5 














How often does a friend or family member:  
 








Help you explain your diabetes care to other family 
or friends 1
 2 3 4 5 
Listen to you when you are stressed about your 
diabetes 1
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This is dedication to my family who has been a constant support for me.  They have been there 
for me in times of frustration.  My father for his guidance and wife for her constant love and 
support.   
  





Thank you to Drs. Patton and Rundio my advisors for your constant support and guidance 
throughout this project 
 
Thank you to Angie my editor who helped make sense of everything 
